全文获取类型
收费全文 | 3958922篇 |
免费 | 333353篇 |
国内免费 | 29538篇 |
专业分类
耳鼻咽喉 | 53267篇 |
儿科学 | 119500篇 |
妇产科学 | 102339篇 |
基础医学 | 613491篇 |
口腔科学 | 104974篇 |
临床医学 | 363111篇 |
内科学 | 709737篇 |
皮肤病学 | 99350篇 |
神经病学 | 330756篇 |
特种医学 | 153174篇 |
外国民族医学 | 647篇 |
外科学 | 600185篇 |
综合类 | 145424篇 |
现状与发展 | 70篇 |
一般理论 | 2400篇 |
预防医学 | 319669篇 |
眼科学 | 92727篇 |
药学 | 283767篇 |
186篇 | |
中国医学 | 22207篇 |
肿瘤学 | 204832篇 |
出版年
2022年 | 31190篇 |
2021年 | 65348篇 |
2020年 | 42813篇 |
2019年 | 64633篇 |
2018年 | 78724篇 |
2017年 | 61079篇 |
2016年 | 66576篇 |
2015年 | 83387篇 |
2014年 | 119726篇 |
2013年 | 183819篇 |
2012年 | 120008篇 |
2011年 | 122691篇 |
2010年 | 129309篇 |
2009年 | 130994篇 |
2008年 | 103202篇 |
2007年 | 107797篇 |
2006年 | 117142篇 |
2005年 | 112275篇 |
2004年 | 109551篇 |
2003年 | 99103篇 |
2002年 | 87637篇 |
2001年 | 141221篇 |
2000年 | 135851篇 |
1999年 | 128524篇 |
1998年 | 71532篇 |
1997年 | 68297篇 |
1996年 | 65176篇 |
1995年 | 60372篇 |
1994年 | 54073篇 |
1993年 | 50054篇 |
1992年 | 87710篇 |
1991年 | 82442篇 |
1990年 | 77632篇 |
1989年 | 76352篇 |
1988年 | 70097篇 |
1987年 | 68344篇 |
1986年 | 64043篇 |
1985年 | 63153篇 |
1984年 | 55152篇 |
1983年 | 49569篇 |
1982年 | 43926篇 |
1981年 | 40983篇 |
1980年 | 38536篇 |
1979年 | 44816篇 |
1978年 | 38204篇 |
1977年 | 34662篇 |
1976年 | 31381篇 |
1975年 | 30131篇 |
1974年 | 31594篇 |
1973年 | 30425篇 |
排序方式: 共有10000条查询结果,搜索用时 28 毫秒
991.
992.
993.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
994.
Javed A. Shaik Nima Estharabadi Ronda S. Farah Maria K. Hordinsky 《Experimental dermatology》2020,29(10):1004-1011
Platelet α-granules release growth factors (GFs) that promote healing and tissue regeneration. Platelet-rich plasma (PRP) is shown to be beneficial in treating alopecia, and however, clinical response can be inconsistent. Due to several fold enrichment of platelets secreting large quantities of GFs following PRP injections, heterogeneity in amounts of GFs secreted by platelets may contribute to inconsistent clinical responses. Herein, we evaluated factors that could potentially contribute to heterogeneous secretion of GFs by platelets. We measured platelet secretion of transforming growth factor beta1 (TGFβ1), platelet-derived growth factor (PDGF-BB), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF2) in aliquots of de-identified PRP samples from female patients undergoing therapy in the hair disease clinic. Although secretion of GFs by platelets was comparable in PRP samples of patients with non-cicatricial and cicatricial alopecia, a Shapiro-Wilk test for normal distribution indicated significant variability across all patient samples. The amount of GF secreted by platelets was comparable when PRP prepared from two FDA-cleared devices with distinct techniques were compared. We provide evidence of platelets secreting heterogeneous amounts of GFs within each sample as high and low secretion of random factors could be simultaneously detected. These results suggest inherent heterogeneity in secretion of GFs by platelets in patient samples that are not influenced by the device used to prepare PRP. Since some GFs could have antagonistic effects on hair growth, a balance between amounts of growth promoting and inhibiting factors may be crucial in determining clinical response to PRP therapy. 相似文献
995.
目的 初步探讨应用艾尔巴韦/格拉瑞韦治疗慢性丙型肝炎(CHC)患者的疗效。方法 2017年3月~2018年3月仙桃市第一人民医院感染病科收治的CHC患者82例,被随机分为对照组41例和观察组41例,分别给予聚乙二醇干扰素-α联合利巴韦林治疗和艾尔巴韦/格拉瑞韦治疗,两组均连续治疗24周。采用RT- PCR法检测血清 HCV RNA,采用全基因序列测定法行病毒基因分型。比较两组早期病毒学应答(EVR)、治疗结束时病毒学应答(ETVR)和持续病毒学应答(SVR)。结果 在治疗结束时,观察组血清丙氨酸氨基转移酶(ALT)水平为(47.9±19.7)U/L,显著低于对照组【(63.5±21.2)U/L,P<0.05】,天冬氨酸氨基转移酶(AST)水平为(55.5±22.3)U/L,显著低于对照组【(81.3±25.8)U/L,P<0.05】;观察组EVR、ETVR和SVR分别为48.8%、63.4%和70.7%,与对照组的41.5%、53.7%和65.8%比,无统计学差异(P>0.05);18例观察组非HCV Ⅰ型感染者EVR、ETVR和SVR分别为88.9%、94.4%和88.9%,显著高于同组23例HCV Ⅰ型感染者(分别为52.2%、60.9%和52.2%, P<0.05),而与对照组15例非HCV Ⅰ型感染者比,无统计学差异(分别为86.7%、93.3%和73.3%, P>0.05);观察组SVR12为87.8%(36/41),显著高于对照组的73.2%(30/41,P<0.05)。结论 应用直接抗病毒(DAA)药物艾尔巴韦/格拉瑞韦治疗CHC患者近期疗效达到,但远期疗效似优于标准治疗方案, 值得临床进一步验证。 相似文献
996.
997.
Michael A. Gibney David Fitz-Patrick David C. Klonoff Shahista Whooley Betty Lu Wen Yue 《Current medical research and opinion》2020,36(10):1591-1600
Abstract
Objective
Two similarly designed studies compared user experiences with a second-generation extra-thin-wall, 5-bevel 32?G?×?4?mm pen needle (PN) with redesigned hub versus four thinner commercially available PNs. 相似文献998.
999.